1. Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines
   Hitoshi Masuo et al, 2023, Cancer Science CrossRef
2. n‐6 and n‐3 Fatty acids and their metabolites augment inhibitory action of doxorubicin on the proliferation of human neuroblastoma (IMR‐32) cells by enhancing lipid peroxidation and suppressing Ras, Myc, and Fos
   Anasuya Devi Hari et al, 2018, BioFactors CrossRef
3. A novel cross-communication of HIF-1α and HIF-2α with Wnt signaling in TNBC and influence of hypoxic microenvironment in the formation of an organ-on-chip model of breast cancer
   Manosi Banerjee et al, 2023, Medical Oncology CrossRef
4. Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
   Weixiao An et al, 2019, Frontiers in Pharmacology CrossRef
5. Study on the effects of the different polar group of EPA-enriched phospholipids on the proliferation and apoptosis in 95D cells
   Yao Guo et al, 2021, Marine Life Science & Technology CrossRef
6. Oridonin from Rabdosia rubescens: An emerging potential in cancer therapy – A comprehensive review
   Muhammad Asif Ali et al, 2024, Food Science & Nutrition CrossRef
7. Oridonin upregulates PTEN through activating p38 MAPK and inhibits proliferation in human colon cancer cells
   QIU-XIANG WU et al, 2016, Oncology Reports CrossRef
8. HINT2 triggers mitochondrial Ca2+ influx by regulating the mitochondrial Ca2+ uniporter (MCU) complex and enhances gemcitabine apoptotic effect in pancreatic cancer
   Linghui Chen et al, 2017, Cancer Letters CrossRef
9. Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance
   Xi Liu et al, 2021, Genes & Diseases CrossRef
10. Structural modification of oridonin via DAST induced rearrangement
    Dong-Dong Luo et al, 2018, RSC Advances CrossRef
11. C-reactive protein promotes tongue squamous cell carcinoma chemoresistance by inhibiting the activation of caspase-3/9 via the CD64/AKT/mTOR pathway
    Xiaodong Yan et al, 2021, Human Cell CrossRef
12. In vitro Study of the Antagonistic Effect of Low-dose Liquiritigenin on Gemcitabine-induced Capillary Leak Syndrome in Pancreatic Adenocarcinoma via Inhibiting ROS-Mediated Signalling Pathways
    Wei Wu et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
13. Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity
    Xiang Li et al, 2021, Frontiers in Pharmacology CrossRef
14. Recent advances in oridonin derivatives with anticancer activity
    Pedro J. M. Sobral et al, 2023, Frontiers in Chemistry CrossRef
15. Oridonin enhances the anticancer activity of NVP-BEZ235 against neuroblastoma cells in vitro and in vivo through autophagy
    Li-Di Zhang et al, 2016, International Journal of Oncology CrossRef
16. Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy
    Sajad Fakhri et al, 2022, Frontiers in Oncology CrossRef
17. The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
    Yibo Fu et al, 2021, Cells CrossRef
18. Oridonin promotes G2/M arrest in A549 cells by facilitating ATM activation
    Mingxing Zheng et al, 2017, Molecular Medicine Reports CrossRef
19. Advances in the treatment of pancreatic cancer with traditional Chinese medicine
    Yanhua Zhang et al, 2023, Frontiers in Pharmacology CrossRef
20. Research Progress and Future Development Potential of Oridonin in Pharmacological Activities
    Jinhuan Jiang et al, 2023, Current Molecular Pharmacology CrossRef